Document Detail

Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
MedLine Citation:
PMID:  7828294     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: In healthy human hearts, beta 2-receptor-mediated chronotropic and inotropic responses contribute to the cardiac responses to beta-agonists. A (patho)physiological relevance for beta 2-receptor-mediated responses has so far not been demonstrated, in part because beta 1-receptor-mediated responses to cardiac neuronally released norepinephrine can mask beta 2-receptor-mediated responses. METHODS AND RESULTS: In the present study, we evaluated the blood pressure and heart rate responses to bicycle exercise in cardiac transplant patients (n = 7) compared with patients with essential hypertension (n = 8) on placebo and two doses of the beta 1-selective beta-blocker atenolol (25 and 50 mg/d) and the nonselective beta-blocker nadolol (20 and 40 mg/d), each dose for 1 week using a double-blind, randomized, crossover design. Exercise was performed 3 hours after dosing, using a stepwise increase in load until exhaustion. Exercise performance was less in the transplant patients and significantly further (25%) decreased by nadolol. Exercise caused equivalent increases in plasma norepinephrine in the two groups, but more marked increases in plasma epinephrine in the transplant patients despite less exercise. In the essential hypertension patients, systolic blood pressure increased by 80 mm Hg on placebo and 60 mm Hg on either blocker. The increase in heart rate (by about 75 beats per minute) was inhibited by 10% and 20% by the lower and higher doses, respectively, similar for the two blockers. In contrast, in the transplant patients, systolic blood pressure increased by 60 mm Hg on placebo, but this increase was totally blocked by either blocker. The heart rate increase (by 50 beats per minute on placebo) was blunted (dose related) by either blocker but 50% more by nadolol versus atenolol. CONCLUSIONS: The present study shows that cardiac beta 2-receptors contribute to a clear extent to the heart rate responses to endogenous circulating catecholamines in the absence of cardiac neuronally released norepinephrine. Nonselective beta-blockade probably is less well tolerated in cardiac transplant patients compared with beta 1-selective blockade.
F H Leenen; R A Davies; A Fourney
Related Documents :
3314464 - Effect of metoprolol on the submaximal stress test performed early after acute myocardi...
22259614 - Vestibular rehabilitation therapy: review of indications, mechanisms, and key exercises.
38214 - Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
15044714 - Alpha-adrenergic vasoconstrictor tone limits right coronary blood flow in exercising dogs.
17917454 - Activation of the prefrontal cortex during the wisconsin card sorting test (keio versio...
461964 - Effect of exercise stress upon the acute toxicity of adriamycin in mice.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation     Volume:  91     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-02-22     Completed Date:  1995-02-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  685-90     Citation Subset:  AIM; IM    
Hypertension Unit, University of Ottawa Heart Institute, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / pharmacology
Blood Pressure / drug effects
Catecholamines / blood
Cross-Over Studies
Double-Blind Method
Heart / physiopathology*
Heart Rate / drug effects
Heart Transplantation*
Hypertension / physiopathology
Middle Aged
Receptors, Adrenergic, beta-2 / physiology*
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Catecholamines; 0/Receptors, Adrenergic, beta-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital...
Next Document:  Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group.